RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Bachem Holding Stock

Bachem Holding ROCE 2024

Bachem Holding ROCE

0.1

Ticker

BANB.SW

ISIN

CH0012530207

WKN

914589

In 2024, Bachem Holding's return on capital employed (ROCE) was 0.1, a -9.92% increase from the 0.11 ROCE in the previous year.

Bachem Holding Aktienanalyse

What does Bachem Holding do?

The Bachem Holding AG is a leading provider of peptides and biochemical agents for the pharmaceutical and biotechnological industry. The company was founded in 1971 in Bubendorf, Switzerland, and has been listed on the Swiss stock exchange since 1998. The company's history began with the founding of Bachem Chemie GmbH by Peter Grogg, a former chemical engineer at Ciba-Geigy. Grogg started the company with a focus on peptide synthesis, an area that was still in its infancy at the time. Over time, Bachem expanded its core business by entering into other areas such as peptide formulation, plant extract manufacturing, and nucleotide synthesis. Today, the company has around 1,400 employees worldwide and operates production and research facilities in Europe, North America, and Asia. Bachem is considered one of the largest peptide manufacturers globally and supplies customers in over 100 countries. The business model of Bachem Holding AG is heavily focused on research and development (R&D). The company invests approximately 15% of its revenue annually in R&D to maintain and expand its leading position in peptide chemistry and biochemical agents. These investments have allowed Bachem to offer a wide range of products and services that meet various customer requirements. The company operates several business segments, including peptides and biochemicals, pharmaceutical contract manufacturing and GMP manufacturing, generic drugs, research services, and products for the diagnostics market. The peptides and biochemicals segment is the core of the company and includes a wide range of peptides, amino acids, peptide libraries, peptide-drug conjugates, synthetic proteins, and bioactive peptides. Bachem also manufactures synthetic peptide kits and customized peptides for research and development. The company is also active in pharmaceutical contract manufacturing, offering customized manufacturing services for bioactive peptides, synthetic drugs, oligonucleotides, and drug-drug conjugates. Customers can benefit from synthesis development to commercial production of active substances. Bachem has also positioned itself in the generic drug market, offering a wide range of peptide-based generics such as buserelin, leuprorelin, and triptorelin. The generic drugs segment was expanded in 2015 through the acquisition of the American biotechnology company American Peptide Company. In addition to manufacturing peptides and biochemical agents, Bachem also provides research services, including peptide synthesis, peptide conjugation with drugs, analysis of protein-protein interactions, and identification of peptide libraries. The company is also active in the diagnostics market, offering a wide range of peptides and antibodies for use in diagnostic products for research and clinical applications. In summary, the Bachem Holding AG is a leading provider of peptides and biochemical agents for the pharmaceutical and biotechnological industry. The company heavily invests in research and development and offers a wide range of products and services to meet various customer requirements. Bachem Holding ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Bachem Holding's Return on Capital Employed (ROCE)

Bachem Holding's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Bachem Holding's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Bachem Holding's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Bachem Holding’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Bachem Holding stock

What is the ROCE (Return on Capital Employed) of Bachem Holding this year?

The ROCE of Bachem Holding is 0.1 undefined this year.

How has the ROCE (Return on Capital Employed) of Bachem Holding developed compared to the previous year?

The ROCE of Bachem Holding has increased by -9.92% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Bachem Holding?

A high Return on Capital Employed (ROCE) indicates that Bachem Holding has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Bachem Holding?

A low ROCE (Return on Capital Employed) can indicate that Bachem Holding has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Bachem Holding impact the company?

An increase in the ROCE of Bachem Holding can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Bachem Holding affect the company?

A decrease in ROCE of Bachem Holding can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Bachem Holding?

Some factors that can affect Bachem Holding's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Bachem Holding so important for investors?

The ROCE of Bachem Holding is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Bachem Holding take to improve the ROCE?

To improve the ROCE, Bachem Holding can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Bachem Holding pay?

Over the past 12 months, Bachem Holding paid a dividend of 0.37 CHF . This corresponds to a dividend yield of about 0.52 %. For the coming 12 months, Bachem Holding is expected to pay a dividend of 0.39 CHF.

What is the dividend yield of Bachem Holding?

The current dividend yield of Bachem Holding is 0.52 %.

When does Bachem Holding pay dividends?

Bachem Holding pays a quarterly dividend. This is distributed in the months of May, May, May, May.

How secure is the dividend of Bachem Holding?

Bachem Holding paid dividends every year for the past 26 years.

What is the dividend of Bachem Holding?

For the upcoming 12 months, dividends amounting to 0.39 CHF are expected. This corresponds to a dividend yield of 0.55 %.

In which sector is Bachem Holding located?

Bachem Holding is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bachem Holding kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bachem Holding from 4/30/2024 amounting to 0.4 CHF, you needed to have the stock in your portfolio before the ex-date on 4/26/2024.

When did Bachem Holding pay the last dividend?

The last dividend was paid out on 4/30/2024.

What was the dividend of Bachem Holding in the year 2023?

In the year 2023, Bachem Holding distributed 0.35 CHF as dividends.

In which currency does Bachem Holding pay out the dividend?

The dividends of Bachem Holding are distributed in CHF.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Bachem Holding

Our stock analysis for Bachem Holding Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bachem Holding Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.